These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 25167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ.
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [Abstract] [Full Text] [Related]

  • 5. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J, Rauh CE.
    Eur J Pharmacol; 1979 Apr 15; 55(2):215-8. PubMed ID: 456420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM, Cuculic Z.
    J Clin Pharmacol; 1976 Jan 15; 16(1):60-5. PubMed ID: 1107360
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of antipsychotic drugs on body weight: a retrospective review.
    Doss FW.
    J Clin Psychiatry; 1979 Dec 15; 40(12):528-30. PubMed ID: 40965
    [Abstract] [Full Text] [Related]

  • 13. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.
    Lee T, Tang SW.
    Psychiatry Res; 1984 Aug 15; 12(4):277-85. PubMed ID: 6239298
    [Abstract] [Full Text] [Related]

  • 14. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
    Tuason VB, Escobar JI, Garvey M, Schiele B.
    J Clin Psychiatry; 1984 Apr 15; 45(4):158-63. PubMed ID: 6370967
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP, Simpson GM, Dunnett CW, Kiltie H.
    Psychopharmacology (Berl); 1977 Jan 31; 51(2):107-15. PubMed ID: 14350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB, McClure RF, Helwig H.
    Curr Ther Res Clin Exp; 1976 Jun 31; 19(6):645-52. PubMed ID: 819222
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.